S&S Healthcare Holding Ltd.
S&S Healthcare Holding Ltd. focuses on the research and development, manufacture, and sale of medical imaging devices in Taiwan, the United States, Switzerland, and internationally. It develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd… Read more
S&S Healthcare Holding Ltd. (4198) - Net Assets
Latest net assets as of June 2024: NT$369.43 Million TWD
Based on the latest financial reports, S&S Healthcare Holding Ltd. (4198) has net assets worth NT$369.43 Million TWD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$565.05 Million) and total liabilities (NT$195.62 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$369.43 Million |
| % of Total Assets | 65.38% |
| Annual Growth Rate | 41.8% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 59.89 |
S&S Healthcare Holding Ltd. - Net Assets Trend (2019–2023)
This chart illustrates how S&S Healthcare Holding Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for S&S Healthcare Holding Ltd. (2019–2023)
The table below shows the annual net assets of S&S Healthcare Holding Ltd. from 2019 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | NT$404.09 Million | +87.58% |
| 2022-12-31 | NT$215.42 Million | +128.70% |
| 2021-12-31 | NT$94.19 Million | +38.95% |
| 2020-12-31 | NT$67.79 Million | -32.18% |
| 2019-12-31 | NT$99.96 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to S&S Healthcare Holding Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 40403200000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$16.45 Million | 5.47% |
| Common Stock | NT$241.08 Million | 80.16% |
| Other Components | NT$43.21 Million | 14.37% |
| Total Equity | NT$300.74 Million | 100.00% |
S&S Healthcare Holding Ltd. Competitors by Market Cap
The table below lists competitors of S&S Healthcare Holding Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Global Power Solutions Corp.
V:PWER
|
$6.19 Million |
|
Ultimovacs ASA
OL:ULTI
|
$6.19 Million |
|
Alphageo (India) Limited
NSE:ALPHAGEO
|
$6.19 Million |
|
NORTHROP GRUMMAN - Dusseldorf Stock Exchang
DU:NTH
|
$6.19 Million |
|
Emmbi Industries Limited
NSE:EMMBI
|
$6.19 Million |
|
Outback Goldfields Corp
OTCQB:OZBKF
|
$6.18 Million |
|
Function International PCL
BK:FTI
|
$6.18 Million |
|
Excelsior Capital Ltd
AU:ECL
|
$6.18 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in S&S Healthcare Holding Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 135,255,000 to 300,737,000, a change of 165,482,000 (122.3%).
- Other factors increased equity by 165,482,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$0.00 | -0.0% |
| Other Changes | NT$165.48 Million | +55.03% |
| Total Change | NT$- | 122.35% |
Book Value vs Market Value Analysis
This analysis compares S&S Healthcare Holding Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.40x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 3.33x to 6.40x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | NT$11.75 | NT$39.15 | x |
| 2020-12-31 | NT$5.17 | NT$39.15 | x |
| 2021-12-31 | NT$3.41 | NT$39.15 | x |
| 2022-12-31 | NT$6.12 | NT$39.15 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently S&S Healthcare Holding Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -49.45%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -26.29%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 3.93x
- Recent ROE (-49.45%) is above the historical average (-136.20%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -152.45% | -83.85% | 0.61x | 2.98x | NT$-162.38 Million |
| 2020 | -169.44% | -113.32% | 0.35x | 4.25x | NT$-121.64 Million |
| 2021 | -173.47% | -77.97% | 0.42x | 5.35x | NT$-100.89 Million |
| 2022 | -49.45% | -26.29% | 0.48x | 3.93x | NT$-80.41 Million |
Industry Comparison
This section compares S&S Healthcare Holding Ltd.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,274,214,400
- Average return on equity (ROE) among peers: 6.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| S&S Healthcare Holding Ltd. (4198) | NT$369.43 Million | -152.45% | 0.53x | $6.19 Million |
| Health & Life Co., Ltd. (1781) | $372.58 Million | -4.71% | 1.15x | $12.97 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.65 Million |
| Wellell Inc (4106) | $1.31 Billion | 13.81% | 0.24x | $37.12 Million |
| Rossmax International Ltd (4121) | $1.33 Billion | 1.93% | 1.30x | $38.32 Million |
| United Orthopedic (4129) | $1.77 Billion | 7.55% | 0.46x | $300.33 Million |
| Dynamic Medical Technologies (4138) | $1.76 Billion | 11.67% | 0.71x | $39.41 Million |
| Ok Biotech Co Ltd (4155) | $1.30 Billion | 9.66% | 0.71x | $44.61 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $30.42 Million |
| EPS Bio Technology Corp. (4183) | $309.15 Million | 10.25% | 0.77x | $4.27 Million |